Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2901_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
12 Мб
Скачать
☆
88 Clinical Cases
https://t.me/medicina_free
Key points
Preparation
Find a quiet and private location
Avoid giving bad news over the phone if possible
Consider whether the patient may want a friend or family member present
Turn off bleeps and mobile phones
Consider booking a double appoint­ment if in a clinic setting
Ensure that you have read through the notes and are familiar with all of the facts
Communication
Establish what patient already knows
Avoid jargon and abbreviations
Pause to check understanding
Give a warning shot before breaking the news
Consider how much detail the patient may or may not wish to know – follow patient cues
Reassure without providing false hope
Closing
Explain next steps
Arrange appropriate follow-up, e.g. with specialist nurses
Give written material if possible
Given the presence of bone metastases, the con­sultant asks the junior doctor to add on a calcium level to the morning bloods.
Malignancy
Related to malignancy directly
– Ectopic PTH, calcitriol or parathyroid
hormone-related peptide production
Related to bone metastasis
– Uncommon but can occur with
mesothelioma
– More common tumours to metasta-
sise to bone include lung, breast, renal and myeloma
Medication-induced, e.g. thiazide diuretics, lithium
Rhabdomyolysis
yrotoxicosis
Phaeochromocytoma
Primary adrenal insufficiency
Sarcoidosis
Tuberculosis
Tertiary hyperparathyroidism
Approximately 90% of cases of hypercalcaemia are due to either primary hyperparathyroidism or malignancy.
What are the symptoms of hypercalcaemia?
Nausea and vomiting
Polyuria
Low mood and confusion
Weakness
Abdominal pain
Arrhythmias (shortened QTc)
Drowsiness
Constipation
How should hypercalcaemia be managed?
TIMEPOINT  3
Later that day, the junior doctor on the ward is chasing up Mrs North’s blood test results. Her calcium comes back as 3.4 mmol/L.
What are the causes of hypercalcaemia?
Primary hyperparathyroidism
Check renal function, liver function, thyroid function, myeloma screen, phosphate levels and parathyroid hormone levels to look for an underlying cause. Assess fluid balance and perform an ECG
Rehydration with 0.9% sodium chloride
Give 4–6 litres over 24 hours
Consider giving loop diuretics if fluid overload (monitor elderly patients or
Case 17: Timepoint 4 89
https://t.me/medicina_free
Table 17.1 Examples of anticipatory medications and sample doses
Sample syringe driver dose
Sample subcutaneous
Symptom Medication
Pain
(opioid-naïve)
Pain
(already using morphine)
Breathlessness Midazolam 2.5 mg 2–4 hourly 10–20 mg/24 hours Nausea Cyclizine 50 mg 8 hourly 100–150 mg/24 hours Secretions Glycopyrronium
Anxiety and
agitation
Delirium and
agitation
Morphine
sulphate
Morphine
sulphate
bromide
Midazolam 2.5–5 mg 2 hourly 10–20 mg/24 hours
Haloperidol 1.5–3 mg 2 hourly 1.5–10 mg/24 hours
2.5–5 mg 2–4 hourly 10–20 mg/24 hours
Divide total daily oral
e.g. current dose 30 mg
0.2 mg 6 hourly 0.6–1.2 mg/24 hours
PRN dose
morphine dose by 12
MST BD = 60 mg per day 60 ÷ 12 hourly
= 5 mg 2–4
(continuous subcutaneous
infusion/CSCI)
Divide total daily oral morphine
dose by 2
e.g. current dose 30 mg MST BD
= 60 mg per day 60 ÷ 2
mg over 24 hours
= 30
those with renal impairment carefully). Consider need for dialysis if severe renal impairment
●
Intravenous bisphosphonates
●
Give aer rehydration
●
Take 2–4 days to reach full eect
●
Options
– Zoledronic acid 4 mg over
15minutes
– Pamidronate 30–90 mg at
20 mg/hour
– Ibandronic acid 2–4 mg
●
Second-line treatments include prednisolone, calcitonin and cinacalcet. Parathyroidectomy may be required in severe acute primary hyperparathyroidism
TIMEPOINT  4
e next day, aer aggressive uid resuscitation, Mrs North’s calcium is rechecked, and it has gone down to 2.8 mmol/L.
Mrs North is reviewed by the oncology con­sultant and palliative care specialist nurse on the ward in the aernoon. e consultant explains that due to her extensive disease, unfortunately
active management would not be appropriate. Aer a long and dicult discussion, Mrs North agrees not to undergo any further active treat­ment. e palliative nurse suggests that she con­sider going to a hospice for symptom control as she is still requiring signicant input to manage her breathlessness. Mrs North agrees to this.
What medications should be prescribed for a palliative discharge?
‘Just in case’ or ‘anticipatory’ medications may be given in hospital to patients nearing the end of life to help with symptom management. Patients may also be given the medications to go home with (to be administered by a district nurse) or if they are going to a hospice as a palliative discharge. ese medications can be given subcutaneously when needed or through a syringe driver. Most trusts will have a guideline regarding their preferred choices for anticipatory prescribing, but Table
17.1 summarises some of the common medica­tions used and their doses. Remember that elderly or frail patients, or patients with renal or liver impairment, may require reduced doses.
90 Clinical Cases
https://t.me/medicina_free
Mrs North is discharged to the local hospice. She passes away 2 weeks later. e hospice doctor is called to conrm her death.
What is the process for confirming the death of a patient?
●
Conrm the identity of the patient by check­ing their wristband
●
Observe for signs of life throughout
●
Check for a response to verbal and painful stimulus
●
Check the appearance of the pupils (dilated and xed with no response to light)
●
Assess for 3 minutes in total for the presence of
●
Respiratory sounds on auscultation
●
Heart sounds on auscultation
●
Carotid or other central pulse
●
It is good practice to palpate for a pacemaker as these need to be removed if the patient has requested to be cremated
●
Document the time and date of death
●
If possible, document who was present at time of death
●
Include your name, designation and GMC number
Case 18
https://t.me/medicina_free
TIMEPOINT  1
Mrs Moloney is a 64-year-old cleaner who pres­ents to the emergency department as she has been feeling unwell all week, and when she checked her temperature at home had a fever of 38.7°C. She has had a cough and shortness of breath for 6 days and was started on antibiotics for a pre­sumed chest infection by her GP 4 days ago. However, she feels that her condition has been deteriorating despite the antibiotics, and she has now started coughing up thick green sputum. She denies chest pain, weight loss and haemoptysis.
Her only past medical history is type 2 diabe­tes, for which she takes metformin 1 g BD. She has never smoked and drinks only 1 or 2 small glasses of wine a night. She spent a week in Spain around 8 months ago, but has not travelled since then.
Mrs Moloney has already been put on 24% oxygen by the triage nurse.
Her observations show:
Respiratory rate: 24/min Oxygen saturations: 97% on 24% oxygen Temperature: 38.4°C Blood pressure: 132/59 mmHg Heart rate: 88 bpm
Her heart sounds are normal, but she has decreased expansion over the right hemithorax, with a stony dull percussion note, reduced breath sounds and reduced vocal resonance at the right base. Abdominal and neurological examination are unremarkable.
e emergency doctor is concerned that Mrs Moloney may have developed a pleural effusion as a result of a chest infection.
What investigations should be arranged at this stage?
Bloods
FBC – infection, anaemia
U&Es – baseline cause of effusion
CRP – infection
LFTs – atypical pneumonia, liver failure as cause of effusion
BNP – heart failure
Chest X-ray
Initial blood test results are given in Table 18.1.
e chest radiograph shows a moderate-sized,
right-sided pleural effusion.
Table 18.1 Venous blood tests
Haemoglobin 126 g/L
9
White cell count 14.3 × 10 Neutrophils 11.2 × 10 Lymphocytes 1.4 × 10 Platelets 464 × 10 Sodium 136 mmol/L Potassium 3.9 mmol/L Urea 7.4 mmol/L Creatinine 87 µmol/L Bilirubin 13 µmol/L ALT 29 U/L AST 26 U/L Albumin 37 g/L Protein 72 g/L Glucose 5.9 mmol/L CRP 112 mg/L LDH 210 U/L
/L
9
/L
9
/L
9
/L
DOI: 10.1201/9781351257725-18
91
92 Clinical Cases
https://t.me/medicina_free
In light of the initial investigation findings, what further investigations should be arranged?
An ultrasound-guided pleural aspiration should be arranged. It is important to check that the patient has a normal clotting profile first.
When sending a pleural aspiration, what tests should be requested?
Samples should be sent for the following:
Biochemistry: protein, LDH, glucose, lactate
Microbiology: MC&S, acid fast bacilli stain­ing and culture
pH
Cytology
In some hospitals, it is possible to check glucose, lactate and pH on a blood gas analyser to get instant point of care results.
TIMEPOINT  2
Two hours later, Mrs Moloney has been admitted to the ward. e ward doctor is able to see some of the preliminary results which are available from the pleural aspiration.
Results of pleural aspiration
Protein 44 g/L LDH 315 U/L Glucose 3.1 mmol/L pH 7.42
Into which two categories can pleural effusions be divided? Discuss the criteria used to distinguish between the categories.
Pleural fluid protein/serum protein ratio >0.5
Pleural fluid LDH/serum LDH ratio >0.6
Pleural fluid LDH >2/3 of the upper limit of normal for serum LDH
Transudates are caused by decreased oncotic pres­sure or increased hydrostatic pressure. Common causes of transudates are le ventricular failure, nephrotic syndrome and liver cirrhosis. Exudates are caused by increased capillary permeabil­ity. Common causes of exudates are infections, malignancy and connective tissue disease.
How should Mrs Moloney be managed?
Mrs Moloney’s pleural effusion is an exudate, with a history and test results suggestive of a parapneumonic effusion. She therefore requires appropriate antibiotic treatment.
e ward doctor starts Mrs Moloney on IV co­amoxiclav 1.2 g TDS and oral clarithromycin 500 mg BD, in accordance with local microbiol­ogy guidelines.
TIMEPOINT  3
Five days aer admission, the ward doctor is called to see Mrs Moloney as she is spiking a tem­perature of 39.2°C, despite having taken 4 days of intravenous antibiotics. She asks the nurse to repeat her observations.
Her observations show:
Respiratory rate: 28/min Oxygen saturations: 94% on 2 L oxygen via nasal
cannulae Temperature: 39.2°C Blood pressure: 104/75 mmHg Heart rate: 124 bpm
Pleural effusions can be divided into transu-
dates and exudates using Light’s criteria.
Pleural fluid is considered to be exudative if it
meets any of the following criteria:
On examination, she still has a dull-sounding right base with coarse crackles in the midzone.
e doctor requests a repeat chest X-ray. See Figures 18.1 and 18.2.
Figure 18.1 The chest X-ray shows a right sided
https://t.me/medicina_free
pleural effusion, which appears more complex; suggestive of an empyema.
Case 18: Timepoint 4 93
Later that eveni ng, the microbiolog y lab phones through to the ward to inform them that pus cells have been seen in Mrs Moloney’s pleural fluid.
What is the diagnosis, and how should Mrs Moloney be managed?
Pus cells in the pleural fluid are indicative of an empyema. Empyema has a 15% mortality rate, so senior-led management is important. e pus needs to be drained from the pleural space. is can oen be done with a chest drain, but up to 30% require surgical drainage via thoracoscopy (VATS). e case should be discussed with a thoracic surgeon. VATS has no mortality benefit over simple chest drain insertion, but does reduce length of admission. CT imaging will allow a bet­ter assessment of the degree of loculation, and will inform the decision as to whether to man­age with VATS. e evidence suggests that flush­ing the chest drain with fibrinolytics does not improve the outcome.
Appropriate antibiotic therapy should be discussed with a microbiologist and should be guided by microscopy, culture and sensitivity of the pleural fluid. e organism responsible for the empyema is usually the same organism responsible for the pneumonia, and knowledge of local conditions should guide empiric treatment. Aminoglycosides (e.g. gentamicin, streptomy­cin) are not effective at low pH and should not be used. Duration of antibiotic therapy should be guided by the identity of the organism and its sensitivities, and by clinical response. Oen 4–6 weeks is recommended.
Figure 18.2 The white outline on the same
image (Figure 18.1) demarcates the loculated nature of the effusion. Generally, empyemas tend to form a lenticular shape (biconvex) against the chest wall.
Aer viewing the results, the ward doctor calls the on-call respiratory registrar who agrees to help with a pleural aspiration. ick, cloudy fluid is aspirated from the pleural space under ultra­sound guidance.
TIMEPOINT  4
Two hours later, the night-shi medical registrar receives a handover from the day team that an urgent chest drain is required for an empyema. Unfortunately, it was not done during the eve­ning shi as the team was busy attending to a peri-arrest patient.
e medical registrar prepares their equip­ment for the chest drain and consents Mrs Moloney.
94 Clinical Cases
https://t.me/medicina_free
What are the complications of chest drain insertion?
Pain
Failed procedure (incorrectly sited)
Bleeding
Infection
Pneumothorax
Haemothorax
Damage to intercostal nerve
Pulmonary oedema
Organ damage
e registrar explains the procedure, including the risks and benefits, and answers all of Mrs Moloney’s questions. She agrees to go ahead with the procedure.
e registrar sets up his sterile field, cleans the area for insertion and gives local anaes­thetic. He then inserts the needle into the pleu­ral space and advances the guidewire. He makes a small incision and then passes the dilator over the guidewire, and then finally passes the chest drain over the guidewire. As soon as the tubing is connected, frank blood is seen in the tubing. e blood pressure machine shows 78/43 mmHg. e tube continues to drain blood and Mrs Moloney stops responding. e doctor pulls the emergency buzzer and a nurse quickly runs in with a crash trolley. e healthcare assistant puts out a crash call whilst the registrar and the nurse commence advanced life support.
Hypoxia
Hypovolaemia
Hypokalaemia/hyperkalaemia/other meta­bolic derangement
Hypothermia
Toxins
Tension pneumothorax
Tamponade (cardiac)
Thrombosis (coronary or pulmonary)
e likely causes in this scenario are either a car­diac tamponade or a hypovolaemic arrest.
e rest of the crash team arrive and continue advanced life support. A bedside ultrasound scan shows no evidence of tamponade, so Mrs Moloney is treated as a hypovolaemic arrest sec­ondary to iatrogenic large vessel trauma from the chest drain insertion. Unfortunately, despite the best efforts of the team, they are unable to resus­citate Mrs Moloney, and aer six cycles the deci­sion is made to stop.
FURTHER READING
1. Case study with parallels to Timepoint4:
VignauCano J.M., Bermúdez García A., Macías Rubio D. Lesión de aorta torácica portubo pleural. Med Intensiva. 2019;43:192. DOI: 10.1016/j. medine.2019.01.005
What reversible causes should be considered during advanced life support? What are the likely causes in this case?
e causes can be summarised as the 4 Hs and the 4 Ts.
Case 19
https://t.me/medicina_free
TIMEPOINT  1
Mr Williams is a 58-year-old plumber who attends his GP complaining of a cough. He is starting to worry that the cough has been going on for too long which is why he has presented today. He guesses that it has been going on for at least 6 months now, but probably less than a year. e cough is sometimes productive, but the sputum is always clear. He denies being breath­less at rest, although he admits that he is increas­ingly breathless on exertion which is starting to interfere with his work. He also struggles to keep up with his wife when they are out walking. He denies having any chest pain, any difficulty sleep­ing due to breathlessness or any weight loss. He has never coughed up any blood.
In terms of past medical history, Mr Williams has well-controlled hypertension. He has also had adhesive capsulitis of the le shoulder in the past, and a right-sided Colles’ fracture many years ago. e GP notes that over the last few years Mr Williams has seemed to present recurrently in the winter months with respiratory tract infections and has received numerous courses of antibiot­ics for these. He takes ramipril 5 mg daily, and has no allergies that he is aware of. He drinks a couple of pints of lager each evening at the pub, and smokes around 30–40 cigarettes a day. He says that he has been smoking for 40 odd years now so is really struggling to cut down, although he knows that he should.
On examination he appears well, with no obvious signs of respiratory distress.
His observations are:
Respiratory rate: 22/min Oxygen saturations: 94% on room air
Temperature: 36.6°C Blood pressure: 129/85 mmHg Heart rate: 84 bpm
On examination, he is warm and well perfused peripherally with a capillary refill time of less than 2 seconds and no evidence of cyanosis. His pulse is approximately 80 beats per minute and regular. His JVP is not raised. His trachea is cen­tral with a reduced cricosternal distance. On aus­cultation, wheezing can be heard throughout the lung fields, but no crepitations. ere is no evi­dence of sacral or pedal oedema.
e GP wonders if COPD might be a good explanation for Mr Williams’ symptoms, given his extensive smoking history.
What initial investigations should be carried out if COPD is suspected?
Calculation of BMI
Full blood count to assess for anaemia or
polycythaemia
Chest X-ray to exclude other lung pathologies
Spirometry, including post-bronchodilator
testing, should be performed at diagnosis
Sputum culture should be considered in order
to identify organisms if sputum is purulent
Serial peak flow measurements should be
considered in order to exclude asthma if there
is still uncertainty regarding the diagnosis
ECG, BNP and echo should be considered if
there is a history of cardiovascular disease or
features of pulmonary hypertension
Serum alpha-1 antitrypsin should be consid-
ered if the patient is younger than 35 years,
or has a minimal smoking history, or has a
family history of lung disease
DOI: 10.1201/9781351257725-19
95
96 Clinical Cases
https://t.me/medicina_free
What advice could Mr Williams be given regarding smoking cessation, irrespective of his spirometry results?
Smoking cessation is a key element of lifestyle management of COPD
Patients with COPD should be offered smok­ing cessation advice at every healthcare contact
is may include brief advice, behavioural support, nicotine replacement therapy, var­enicline or bupropion if needed
Current evidence suggests that e-cigarettes are significantly less dangerous than smoking but are not completely risk-free, and the long-term impact of their use is still unknown
If a patient is not yet ready to stop smoking, remind them again of the benefits of stopping and encourage them to seek help in the future when they feel more ready
The GP discusses smoking cessation with Mr Williams, and he agrees to try a course of var­enicline and referral to a behavioural support programme. She prescribes him a salbuta­mol inhaler to use as required, and refers him for spirometry at the local hospital. She also requests that he be assessed for pulmonary rehabilitation.
TIMEPOINT  2
One week later, the GP reviews Mr Williams’ spi­rometry results.
What would you expect to see on spirometry?
You would expect to see evidence of obstructive air­way disease, defined as a post-bronchodilator FEV1/ FVC <0.7. Severity can then be stratified using the FEV1 as a percentage of the predicted value.
Spirometry is an important tool both for diagno­sis but also for the monitoring of disease progres­sion. Although the level of airway obstruction does not correlate well with the extent of the patient’s disability, it helps to guide treatment and estimate prognosis.
Spirometry demonstrates an FEV1/FVC of 0.63 and FEV1 58% of predicted.
e GP phones Mr Williams to ask him how he is getting on. He reports that he does not think the blue inhaler has helped him very much. He has been using it 6–7 times a day when he feels breathless on exertion, but it doesn’t seem to make much difference. e GP explains that the spirometry confirms a diagnosis of COPD, and suggests starting a LAMA-LABA inhaler. She also asks him to book an appointment for influenza and pneumococcal vaccinations. Mr Williams is happy with this plan.
How should inhalers be escalated (Figure 19.1)?
ICS = inhaled corticosteroid
https://t.me/medicina_free
Case 19: Timepoint 2 97
Step 1
Step 2
Step 3
Step 4
Step 5
Optimise patient
Inuenza + pneumococcal vaccinations
Short-acting bronchodilators
DO NOT have asthmatic features or
features suggesting steroid responsiveness
Long-acting bronchodilators
DO have asthmatic features or features
suggesting steroid responsiveness
Breathless or exacerbations despite LABA-ICS
Triple therapy
Home nebulisers – if distressing symptoms despite maximal inhaler therapy Oral steroids – if unable to wean following exacerbation Oral theophylline – if unable to use, or poor response to inhalers Oral mucolytics – if chronic productive cough Oral prophylactic antibiotics – if recurrent infections Roumilast – a monoclonal antibody used as an add on bronchodilator
Smoking cessation
Pulmonary rehabilitation
SABA e.g. salbutamol
SAMA e.g.ipratropium
LAMA-LABA e.g
tiotropium-olodaterol
LABA-ICS e.g
budesonide-formoterol
LAMA-LABA-ICS
Provide a spacer
Inhaler technique
KEY:
SABA = short-acting beta-2 agonist SAMA = short-acting muscarinic agonist LABA = long-acting beta-2 agonist LAMA = long-acting muscarinic agonist
Figure 19.1 Escalation of treatment in COPD.
Surgical options for severe COPD
Lung volume reduction
Bullectomy
Lung transplant
How can COPD be staged?
Either using post-bronchodilatory FEV1 (GOLD scale) (Table 19.1) or using the MRC dyspnoea scale (Table 19.2).